CBD and CBDA are closely related compounds from the same plant, but they differ in chemical structure, how the body absorbs them, and how they interact with biological systems. CBDA is the raw, naturally occurring form found in living hemp and cannabis plants. CBD is what CBDA becomes after exposure to heat. That single chemical change has significant consequences for how each compound behaves in your body.
How CBDA Becomes CBD
In a living cannabis or hemp plant, CBDA is the dominant form. The plant doesn’t actually produce CBD directly. Instead, it synthesizes CBDA, which carries an extra carboxyl group (a cluster of carbon, oxygen, and hydrogen atoms) attached to its molecular ring. When the plant material is heated through smoking, vaping, cooking, or commercial processing, that carboxyl group breaks off and releases carbon dioxide. What remains is CBD. This process is called decarboxylation, and it happens naturally over time with exposure to heat and light, but it accelerates dramatically at higher temperatures.
This is why most CBD oils on the market contain very little CBDA. Lab analyses of commercial CBD oil products found that nearly all samples were partially or totally decarboxylated, with CBDA concentrations below 0.001% in most cases. Even the products with the highest residual CBDA topped out at just 0.44%. If you want meaningful amounts of CBDA, you need raw, unheated hemp extracts, fresh plant juice, or products specifically formulated to preserve it.
Absorption: CBDA Gets Into Your Blood More Easily
One of the most striking differences between these two compounds is how well your body absorbs them. Despite being described as more water-soluble (which usually makes crossing fatty cell membranes harder), CBDA reaches dramatically higher levels in the bloodstream after oral dosing.
A pharmacology study comparing equal oral doses of CBD and CBDA found that CBDA peak plasma concentrations were 25 to 67 times higher than those of CBD. Total exposure over time, measured by the area under the plasma concentration curve, was 14 to 36 times greater for CBDA. CBD’s oral bioavailability is notably poor, estimated at less than 15%, meaning the vast majority of what you swallow never reaches your bloodstream. CBDA appears to be absorbed more efficiently in the gut, or it may avoid being broken down as aggressively by the liver on its first pass through your system. The practical takeaway: a much smaller dose of CBDA could deliver the same or greater blood levels compared to CBD.
Factors like whether you take either compound with food, and what type of formulation it’s in (oil, capsule, tincture), also influence how much ultimately gets absorbed. But across conditions, CBDA consistently outperformed CBD in reaching the bloodstream.
How They Work in the Body
CBD and CBDA don’t act on the same biological pathways, which means their potential effects aren’t interchangeable.
CBD interacts with a broad set of receptor systems. In cancer cell research, for example, CBD treatment activated specific cell growth and signaling pathways (Wnt and Hippo signaling) in colorectal cancer cells. It has documented effects on serotonin receptors, inflammation-related pathways, and various gene expression profiles. CBD is the more extensively studied of the two, with approved pharmaceutical uses for certain types of epilepsy.
CBDA works through different mechanisms. Its most well-characterized action is inhibiting COX enzyme activity, the same enzyme family targeted by common anti-inflammatory drugs like ibuprofen. This has been demonstrated in breast cancer cell research. Interestingly, in the same colorectal cancer study where CBD activated multiple signaling pathways, CBDA treatment showed no significant pathway regulation at all. This doesn’t mean CBDA is inactive. It means its biological effects operate through different channels than CBD’s, and those channels may be more selective or narrower in scope.
Both compounds are non-intoxicating. Neither will produce a high.
Anti-Nausea Effects: Where CBDA Stands Out
The most dramatic performance gap between CBD and CBDA shows up in nausea research. Both compounds reduce nausea in preclinical models, and both work through the same serotonin receptor (5-HT1A). But CBDA was roughly 1,000 times more potent than CBD at suppressing acute nausea in animal studies. That same 1,000-fold potency advantage held for anticipatory nausea, the type that develops before a nausea-inducing event (familiar to many chemotherapy patients who feel sick before treatment even begins).
Neither compound impaired movement or coordination at effective doses, which distinguishes them from THC-based anti-nausea options. This potency difference, combined with CBDA’s superior absorption, makes it a compound of particular interest for nausea management, though human clinical data is still limited.
Which One You’re Actually Getting
If you buy a standard CBD oil, tincture, or capsule, you’re getting CBD. The manufacturing process involves heating the hemp extract, which converts essentially all the CBDA into CBD. Products labeled as “raw” hemp extract, cold-pressed hemp oil, or specifically marketed as CBDA products are your options for getting the acidic form. Some products now offer blends of both.
CBDA is less stable than CBD. It will slowly convert to CBD over time, especially if stored in warm or bright conditions. This means CBDA products have a shorter effective shelf life and require more careful storage, typically in cool, dark places.
The choice between CBD and CBDA depends partly on what you’re looking for. CBD has a much larger body of human research behind it and established regulatory pathways. CBDA offers potentially better absorption and dramatically greater potency for specific effects like nausea reduction, but with less clinical validation in humans. They’re not competing compounds so much as two forms of the same molecule with distinct strengths.